DPP4 and type 2 diabetes mellitus: Previous studies demonstrated that weight loss achieved by administration of SGLT2 inhibitors or short-term hospitalization with calorie restriction can reduce serum sDPP-4/CD26 in people with type 2 diabetes and MASLD.21